KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $55.6 million.

  • Charles River Laboratories International's Consolidated Net Income fell 2096.74% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 11860.32%. This contributed to the annual value of $25.3 million for FY2024, which is 9473.51% down from last year.
  • Charles River Laboratories International's Consolidated Net Income amounted to $55.6 million in Q3 2025, which was down 2096.74% from $52.7 million recorded in Q2 2025.
  • Charles River Laboratories International's Consolidated Net Income's 5-year high stood at $189.1 million during Q4 2022, with a 5-year trough of -$213.7 million in Q4 2024.
  • In the last 5 years, Charles River Laboratories International's Consolidated Net Income had a median value of $94.3 million in 2024 and averaged $80.6 million.
  • Per our database at Business Quant, Charles River Laboratories International's Consolidated Net Income surged by 4894.19% in 2022 and then tumbled by 21312.24% in 2024.
  • Charles River Laboratories International's Consolidated Net Income (Quarter) stood at $139.8 million in 2021, then skyrocketed by 35.24% to $189.1 million in 2022, then fell by 0.08% to $189.0 million in 2023, then tumbled by 213.12% to -$213.7 million in 2024, then soared by 125.99% to $55.6 million in 2025.
  • Its Consolidated Net Income was $55.6 million in Q3 2025, compared to $52.7 million in Q2 2025 and $25.9 million in Q1 2025.